Clinical Trial Update: A Study of MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating MG-K10 monoclonal antibody for Atopic Dermatitis; the study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• MG-K10

Snippet

Sponsor: Shanghai Mabgeek Biotech.Co.Ltd | Conditions: Atopic Dermatitis (AD) | Phase 2 | Status: NOT_YET_RECRUITING